冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市 Apollomics, Inc. Mar 30, 2023 20:31 HKT/SGT Read More
冠科美博(Apollomics Inc.)宣佈完成和SPAC Maxpro合併,並在納斯達克上市 Apollomics, Inc. Mar 30, 2023 20:30 HKT/SGT Read More
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq Apollomics, Inc. Mar 30, 2023 20:29 HKT/SGT Read More
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing Cryoviva Singapore Mar 21, 2023 08:30 HKT/SGT Read More
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing Cryoviva Singapore Mar 21, 2023 08:00 HKT/SGT Read More
Essex Bio-Technology Announces 2022 Annual Financial Results Essex Bio-Technology Limited Mar 08, 2023 20:28 HKT/SGT Read More
亿胜生物与复宏汉霖签订治疗年龄相关性黄斑变性全球共同开发及独家许可协议之经修订协议 Essex Bio-Technology Limited Feb 22, 2023 18:50 HKT/SGT Read More
億勝生物與復宏漢霖簽訂治療年齡相關性黃斑變性全球共同開發及獨家許可協議之經修訂協議 Essex Bio-Technology Limited Feb 22, 2023 18:49 HKT/SGT Read More
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration Essex Bio-Technology Limited Feb 22, 2023 18:48 HKT/SGT Read More
Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks PCG Digital Feb 17, 2023 10:21 HKT/SGT Read More
疫苗开发不断变化的全球格局:Novotech 和 Endpoints News 网络研讨会 Novotech Health Holdings Pte Ltd Feb 16, 2023 08:00 HKT/SGT Read More
백신 개발 발전의 글로벌 환경: 노보텍 및 엔드포인트 뉴스 웨비나 Novotech Health Holdings Pte Ltd Feb 16, 2023 08:00 HKT/SGT Read More
疫苗開發不斷變化的全球格局:Novotech 和 Endpoints News 網絡研討會 Novotech Health Holdings Pte Ltd Feb 16, 2023 08:00 HKT/SGT Read More
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Novotech Health Holdings Pte Ltd Feb 15, 2023 09:00 HKT/SGT Read More
노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장 Novotech Health Holdings Pte Ltd Feb 13, 2023 06:00 HKT/SGT Read More
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Essex Bio-Technology Limited Feb 10, 2023 21:06 HKT/SGT Read More